Recent Updates
Recently added Catalysts
RDY

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com

Key Takeaway: March 14, 2020 The General Manager, The Manager, Corporate Relations Department, The Listing Department, BSE Limited, National Stock Exchange of India Limited, P. J. Towers, Exchange Plaza, Dalal Street, Mumbai - 400001 C-1, Block G, Bandra Kurla Complex, Scrip Code: 500124 Band

Full Press Release Details

March 14, 2020
The General Manager, The Manager,
Corporate Relations Department, The Listing Department,
BSE Limited, National Stock Exchange of India Limited,
P. J. Towers, Exchange Plaza,
Dalal Street, Mumbai - 400001 C-1, Block G, Bandra Kurla Complex,
Scrip Code: 500124 Bandra East, Mumbai - 400051
Symbol: DRREDDY - EQ
We enclose herewith copies of the
newspaper advertisements published in Business Standard (English daily) and Andhra Prabha (Telugu daily), Hyderabad edition on
March 14, 2020 with regard to the hearing of the joint petition for sanction of Scheme of Amalgamation and Arrangement of Dr. Reddy's
Holdings Limited and Dr. Reddy's Laboratories Limited and their respective shareholders pursuant to provisions of Sections
230-232 read with section 66 and other relevant provisions of the Companies Act, 2013 and rules framed thereunder.
The copy of the newspaper publications
are also available on the website of the Company at https://www.drreddys.com/investors/investor-services/amalgamation.
This is for your information and
For Dr. Reddy's Laboratories
/s/ Sandeep Poddar
Sandeep Poddar
Company Secretary
CC:- New York Stock Exchange Inc.(Stock Code :RDY)
NCLT - Notice of Petition -
Business Standard - March 14, 2020
NCLT - Notice of Petition -
Andhra Prabha - March 14, 2020
Last updated: Mar 14, 2020